Christopher Klifto, MD
Mariano Menendez, MD
Julie Y. Bishop, MD
Warren Dunn, MD
April D. Armstrong, MD, FRCSC
Jonathan P. Braman, MD
John G. Costouros, MD, FACS
Charles L. Getz, MD
Jonathan C. Levy, MD
Thomas (Quin) W. Throckmorton, MD
Julie Y. Bishop, MD
Theodore A. Blaine, MD
Xavier A. Duralde, MD
John C. Macy, MD
Eric T. Ricchetti, MD
Brian R. Wolf, MD, MS
Mariano Menendez, MD
Asheesh Bedi, MD
Brad Bushnell, MD
Alison Cabrera, MD
Matthew Saltzman, MD
Charles Jobin, MD
Scott Steinmann, MD
Emilie Cheung, MD
Peter Chalmers, MD
Xavier Duralde, MD
Mark Frankle, MD
Grant Garrigues, MD
Jason Holcomb, MD
Christopher Klifto, MD
William Levine, MD
Wesley Phipatanakul, MD
Thomas Wright, MD
Carolyn Hettrich, MD
Brian Feeley, MD
Eric R. Wagner, MD, MS, Co-chair
Peter Chalmers, MD, Co-chair
Julia Lee, MD, Ex-officio
Brian F. Grogan, MD, Ex-officio
Robert Tashjian, MD, Board Liaison
Armodious Hatzidakis, MD
Niloofar Dehghan, MD
Peter Chalmers, MD
Timothy Griffith, MD
Scott P. Steinmann, MD
Albert Lin, MD, Co-chair
Augustus Mazzocca, MD, Co-chair
Robert A. Arciero, MD
John M. Tokish, MD
Jon JP Warner, MD
Peter B. MacDonald, MD, FRCSC
Matthew Provencher, MD, MBA
Robert J. Gillespie, MD
Christian Gerber, MD
Andrew Jawa, MD
Sara Edwards, MD
Eric Ricchetti, MD
Jonathan Levy, MD
Robert Tashjian, MD
Caroline Chebli, MD
Surena Namdari, MD, MSc
Gary Updegrove, MD
Stephen Brockmeier, MD
Thomas Duquin, MD
Thomas Quin Throckmorton, MD
Lawrence Gulotta, MD
Jay Keener, MD
Charles Getz, MD
Nathan Lanham, MD
John Sperling, MD, MBA
Joaquin Sanchez-Sotelo, MD, PhD
April Armstrong, MD, FRCSC
Anthony Miniaci, MD, FRCSC
Jason Hsu, MD, Chair
Burak Altintas, MD
John Apostolakos, MD, MPH
Seyed Arshad, DO
Daniel Austin, MD
Amir Boubekri, MD
Jonathan Bravman, MD
Daniel Brereton, DO
Mark Callanan, MD
Danielle Casagrande, MD
Jonathan Cheah, MD
Kathleen Collins, MD
Caleb Davis MD
Kenneth Donohue, MD
Kevin Dunne, MD
Travis Frantz, MD
Konrad Gruson, MD
Carlos Guanche, MD
Andy Hartman, MD
Jeffrey Hassebrock, MD
Brian Hill, MD
Ganesh Kamath, MD, MBA
Liam Kane, MD
Evangeline Kobayashi, MD
Logan Kolakowski, MD
Van Krueger, MD, MBA
Jennifer Kurowicki, MD
Simon Lambert, MBBS, FRCS
Kathleen Leinweber, MD, MA
Nicholas Maassen, MD
Alexander Macfarlane, MD
Alexandra Makenzie, DO
Ajith Malige, MD
Nabil Mehta, MD
Prashant Meshram, MS, MBBS, DNB
Angela Passanise, DO
Gabriel Rulewicz, MD
James “Jimmy” Satalich, MD
David Savin, MD
Mihir Sheth, MD
Walt Smith, MD
Ramesh C Srinivasan, MD
Monica Stadecker, MD, MBA
Joshua Sykes, MD
Wame Waggenspack, MD
Kevin Wall, MD, MPH
Asheesh Bedi, MD
Jason Koh, MD
Surena Namdari, MD
Frank Petrigliano, MD
Peter MacDonald, MD
Jed Kuhn, MD, Board Liaison
Brandon Bushnell, MD, Board Liaison
Anna K. Quintanilla, MA
April Armstrong, Chair
Stephanie Muh, MD, Chair
Anand Murthi, MD, Co-Chair
Trenton Gause, MD
Armodios Hatzidakis, MD
Havalee Henry, MD
Marie Eve LeBel, MD
Gabriella Ode, MD
Caroline Park, MD
Corey Schiffman, MD
Mark Schultzel, MD
Michel Ruiz Suarez, MD, PhD
Jie Yao, MD
Julie Bishop, MD, Board Liaison
Melissa Wright, MD, Chair
Justin Griffin, MD, Co-Chair
Jeffrey “Ryan” Hill, MD
Wayne Chan, MD
William Aibinder, MD
Stephen Brockmeier, MD
Raymound Chen, MD
Patrick Noud, MD
Derek Papp, MD
James D. Kelly II, MD, Ex-officio
Matthew Saltzman, MD, Ex-officio
Christopher Klifto, MD, Board Liaison
John D. Kelly, IV, MD, Chair
Jeffrey Abrams, MD, Co-chair
Shane Barton, MD, MS, MBA, MPH
Andy Jensen, MD
Todd O’Brien, MD
Anthony Miniaci, MD, Board Liaison
Jay Keener, MD, Chair
Joseph King, MD, Co-chair
Abdulaziz Ahmed, MD
Joseph Choi, MD
Alex Cikes, MD
John Erickson, MD
Rishi Garg, MD
Mohit Gilotra, MD
Michael Khazzam, MD
Joseph Lamplot, MD
Thay Lee, PhD
Carlos Ramos, MD
Philipp Streubel, MD
Edward Yian, MD
Anthony Miniaci, MD, Board Liaison
Shannon R. Carpenter, MD, Chair
Robert Gillespie, MD, Co-chair
Raymond Edward Chen, MD, Secretary
Casey Beleckas, MD
Michael Del Core, MD
Scott Ellsworth, MD
Michael T. Freehill, MD
John Itamura, MD
Peter Johnston, MD
Ryan Lohre, MD
Jeffrey Lynch, DO
Adam Seidl, MD
Lewis Shi, MD
April Armstrong, MD, Board Liaison
Julie Bishop, MD, Chair
Richard Friedman, MD
Doug Murray, MD
Abner Ward, MD
Craig Satterlee, MD
Anthony Miniaci, MD, Ex-officio
George Athwal, MD, Chair
Graham King, MD, Co-chair
William Levine, MD, Co-chair
Joaquin Sanchez-Sotelo, MD, Co-chair
Joseph Abboud, MD
Emilie Cheung, MD
Patrick Denard, MD
Jonathan Levy, MD
John Sperling, MD
April Armstrong, MD
Peter MacDonald, MD
Brian Wolf, MD
Jeffrey Abrams, MD
Frank Cordasco, MD
Xavier Duralde, MD
Mark Frankle, MD
Felix (Buddy) Savoie, MD
Anthony Romeo, MD
Jeffrey S. Abrams, MD, Co-chair
Bradford O. Parsons, MD, Co-chair
Dave Shukla, MD
Yousif Atwan, MD
Josh Baumfeld, MD
Tyler Brolin
Derek J. Cuff, MD
Joshua S. Dines, MD
Steven D. Levin, MD
Drew V. Miller, MD
Raffy Mirzayan, MD
Brian Shiu, MD
Abner M. Ward, MD, MBA, MA, FACS
Anthony Miniaci, MD
H. Mike Kim, MD
Robert Litchfield, MD
Jason O. Holcomb, MD, Co-chair
Marc S. Kowalsky, MD, Co-chair
Christopher Klifto, MD, Co-chair
Ryan Bicknell, MD
Kyle Flik, MD, FAAOS
Abdullah Foad, MD
Nathan Formaini, MD
Nickolas Garbis, MD
James Gregory, MD
Joanne Labriola, MD
Bryan Loeffler, MD
Marc Lubitz, MD
Ashish Rawal, MD
Brian Shiu, MD
Michael Yip, MD
John E. (Jed) Kuhn, MD, Ex-Officio
James D. Kelly II, MD, Chair
Matthew Saltzman, MD, Co-chair
Frank Alberta, MD
Luke Austin, MD
Kamal Bohsali, MD
Robert Boykin, MD
Tyler Brolin, MD
Greg Cvetanovich, MD
Michael T. Freehill, MD
Daniel Goltz, MD
Gabe Horneff, MD
Christopher Joyce, MD
Lee Kaback, MD
Spero Karas, MD
Michael Knudsen, MD
Jonathan Levy, MD
Jeremy McCallum, MD
John-Erik Bell, MD, MS
Mena Mesiha, MD
Daryl Osbahr, MD
Randall Otto, MD
Kevin Plancher, MD
JR. Rudzki, MD
Kevin Setter, MD
Anup Shah, MD
Sarav Shah, MD
Thomas Wright, MD
Christopher Klifto, MD, Board Liaison
Carolyn Hettrich, MD, Chair
Akin Cil, MD, Co-chair
Andrew S. Neviaser, MD
Bradley S. Schoch, MD
Bryan J. Loeffler, MD
Christopher C. Schmidt, MD
David Kovacevic, MD
Eric T. Ricchetti, MD
J. Gabriel Horneff III, MD
Jason E. Hsu, MD
Jonathan C. Riboh, MD
Jonathan D. Barlow, MD, MS
Josef K. Eichinger, MD
Joseph A. Abboud, MD
Joseph J. King III, MD
Lawrence V. Gulotta, MD
Luke S. Oh, MD
Mark A. Frankle, MD
Mark E. Morrey, MD
Michael H. Amini, MD
Michael J. O’Brien, MD
Peter Simon, PhD
Robert Tashjian, MD, Board Liaison
Acromioclavicular Injury Group. Geoffrey Abrams MD
Controversy exists on the appropriate way to classify and treat acromioclavicular joint injuries. The Acromioclavicular Injury group is addressing these controversies by finding consensus using the Delphi method, looking at failure mechanisms after surgery and developing outcomes measures and collection strategies to set up outcomes database.
B2 Glenoid Group. Eric Ricchetti
Management of posterior glenoid bone loss (Walch B2 and B3 glenoids) in patients indicated for shoulder arthroplasty due to end-stage glenohumeral osteoarthritis can be challenging to address at the time of surgery and has been shown to impact clinical outcomes and implant longevity. The distinguishing features of these pathologies, and the factors associated with clinical and radiographic outcomes with different shoulder arthroplasty options in these patients are still not well understood. Therefore, the mission of the ASES B2 Glenoid Multicenter Research Group is to better understand the defining features of the Walch B2 and B3 glenoid, and to investigate key cohorts of patients with these glenoid morphologies undergoing shoulder arthroplasty to determine the factors related to postoperative clinical and radiographic outcomes at short- and longer-term follow-up.
Complications of Reverse Arthroplasty Group. Larry Gulotta
Our mission is to decrease the rate of complications following reverse shoulder arthroplasty through a multicenter initiative. The first task is to identify the types and rates of various complications using modern implants. A systematic review of all papers on reverse shoulder arthroplasty published after 2010 has recently been submitted for publication as a two-part series. In this study, we determined that most major complications have decreased over the years as implants and techniques have improved. However, acromial and scapular spine stress fractures continue to be a devastating complication that adversely effects the long-term outcome, and for which there are currently limited treatment options. Therefore, the second task is to specifically study acromial and scapular spine stress fractures. Under the direction of Andy Jawa, the members of the task force have compiled our retrospective data on this complication to determine patient and implant-related risk factors. This data has been accepted for presentation at this year’s ASES meeting. The third task will be to use the information learned from the literature review and retrospective studies in order to devise prospective and interventional studies that can further limit complication after reverse shoulder arthroplasty.
Natural History of Shoulder Arthritis. Andy Green
Glenohumeral osteoarthritis is a well-recognized condition that causes shoulder pain and dysfunction. Most of the reported literature on glenohumeral osteoarthritis is focused on the surgical management of advanced stages of the condition. However, patients present with glenohumeral OA in various stages of pathology and with variable severity of clinical manifestations. Although it is assumed that glenohumeral OA is a progressive disease and condition, there is a paucity of information available regarding the progression of pathology and clinical manifestations. The goal of the Natural History of Glenohumeral Osteoarthritis (NHGOA) multicenter study group is to evaluate the clinical and pathologic manifestations of this condition to provide an understanding of the relationship between the pathoanatomy and clinical manifestations of glenohumeral osteoarthritis and the progression of the condition over time.
Periprosthetic Joint Infection Group. Jason Hsu
The ASES Shoulder Periprosthetic Joint Infection (PJI) / Revision Arthroplasty Research group is focused on improving the prevention, diagnosis, and management of infections that occur after shoulder replacement. There currently is little consensus on optimal treatment for potential shoulder PJI. We have established a multicenter REDCap database, and members of this group have been enrolling all consecutive revision arthroplasty patients. A standardized workup for infection has been established. Data from this group will help us optimize diagnosis and treatment of potential infection encountered at revision arthroplasty and will help guide the next iteration of the International Consensus Meeting (ICM) definition for shoulder PJI.
SLAP/Biceps Study Group. Tiger Li
The SLAP/Biceps Study Group is working to outline and understand the history of the superior labral pathology and the biceps tendon and its anchor and attachment. Our intent is to define a new description of the terms utilized to describe and classify superior labral and biceps anchor pathology to better direct diagnosis and treatment through the development of a multi-center, prospective, observational study of athletes and active individuals with injuries to the superior labrum and biceps anchor managed with operative and non-operative treatment. A particular focus will include throwing athletes with the intent to determine the optimal method of diagnosis, classification and treatment through a comprehensive analysis using imaging, functional outcomes and a robust registry capturing specific data focused on return to play.
Partial Thickness Rotator Cuff Tear Group. Mike Kim, Jim Leonard
Partial-thickness rotator cuff tears are one of the most common conditions that are seen and treated in the shoulder and elbow surgery field. Our group is seeking to answer some of the challenging yet fundamental questions about this very common conditions. We are specifically looking at the diagnostic performance of imaging modalities, effectiveness of nonoperative treatment, risk factors for failure of nonoperative treatment, and ultimately optimal treatment decision making for individual patients with a partial-thickness rotator cuff tear.
Shoulder Arthritis in the Young Patient Group. Joseph Abboud
The treatment of glenohumeral osteoarthritis in the young patient remains a challenge for both treating surgeons and patients. Younger patients tend to live more active lifestyles and have longer projected life expectancies, and that can lead to concerns regarding prosthetic longevity and the future need for revision surgery. As such, surgical options for these patients revolve between arthroscopic management and shoulder replacement. The purpose of this study is to determine the survival rate and outcomes of young osteoarthritis patients managed by arthroscopic surgery or by shoulder arthroplasty. The aim is to conduct a multicenter study to follow the patients’ outcomes, extrapolate best treatment strategies, predict complication rates, and derive patient-specific variables that affect prognosis.
Instability with Bone Loss Group. Brian Lau
The ASES Shoulder Instability Bone Loss committee is studying innovative ways to measure and address glenoid and humeral bone loss. We have evaluated the use of 3D MRI and clinical decision making and hope to develop improved techniques of pre-operative assessment of bone loss. We also hope to develop evidence-based indications for utilization of innovative bone block procedures for glenoid bone loss and treatment algorithms for humeral bone loss.
Proximal Humerus Fracture Group. Jay King
The overarching goal of the ASES Proximal Humerus Fracture multicenter group is to help improve the algorithm that surgeons can use to treat proximal humerus fractures. Proximal humerus fractures are one of the most common fractures seen in elderly patients. While fixation is optimal in young patients, a gold standard treatment algorithm to optimize outcomes in elderly patients does not exist. The burden of proximal humerus fractures on the aging population is great and improvements in understanding the optimal treatment for these patients is necessary. The ASES Proximal Humerus Fracture multicenter group is attempting to construct this algorithm starting with identifying the best outcome scores to use, tracking a large cohort of patients treated for proximal humerus fractures to allow for multivariate analysis of the factors associated with good outcomes, and to test this algorithm prospectively. We also want to add to the current literature on nonoperative treatment of these injuries. Our hope is that we can preoperatively identify patients who would benefit from certain treatments including nonoperative treatment, internal fixation, and shoulder arthroplasty and also minimize complications associated with these treatments.
Elbow Arthroplasty Group. Eric Wagner and Michael Gottsalk
In the multicenter TEA group, we have a couple different focuses, including retrospective and national database studies, as well as a prospective randomized controlled trial. The retrospective and database studies are examining the outcomes of various implants, HO occurrence, and incidence/occurrence of home vs formal physical therapy. The prospective study is randomizing patients undergoing primary TEA to in situ vs transposition of the ulnar nerve. We hope these ultimately will serve as a foundation for future intervention related studies to examine common complications after TEA.
Elbow Arthritis in the Young Patient Group. Gabe Horneff
Elbow arthritis is a difficult problem to address given the inherent limitations and rates of complications and failures seen in total elbow arthroplasty when compared to other forms of joint arthroplasty. For this reason, elbow arthroscopy is often utilized in the younger and more active patient population to give relief of pain, improve range of motion, and attempt to prolong the native anatomy for patients. The goal of this group is to understand the mid- and long-term outcomes of surgical treatment for elbow arthritis. We are currently prospectively examining the results of arthroscopic osteocapsular arthroplasty in young patients under the age of 60 to assess how effective the procedure is in providing relief.
Elbow Fracture/Dislocation Group. Akin Cil
The Elbow Fracture/Dislocation group has 15 surgeons from 15 sites all over the USA. We are studying the best way to manage elbow fractures and dislocations, specifically radial head fractures and coronoid fractures. We are working on finding agreement for treating elbow injuries and will be enrolling patients in a randomized trial to look at radial head prostheses (smooth versus porous coated) for severe radial head fractures, and also improve understanding and management of coronoid fracture management.
IMOCD Elbow OCD Group. Mohit Gilotra
Elbow Osteochondritis Dissecans is a common injury in adolescent athletes with a wide range of potential imaging for diagnosis and both nonoperative and operative treatments. Differences in care vary by patient age, size and location of lesion, sport, and region/continent. Our goal is to determine the best modalities for diagnosing lesions that are unstable and that may require surgery. We also want to optimize patient and lesion specific treatment for faster return to play and prevention of long-term arthritis. Long term we are creating a prospective international registry to answer these challenging questions.
Elbow Stiffness Group. Bryan Loeffler
The mission of the elbow stiffness group is to conduct well designed, multicenter studies that will answer the clinical questions of how to best prevent and treat post-traumatic elbow stiffness. Planned studies include comparing operative techniques, postoperative rehab strategies, psychological barriers to improving elbow range of motion, and pharmacologic interventions to improve patient care.
Peter B. MacDonald, MD, Chair
T. Bradley Edwards, MD
Lawrence Gulotta, MD
Andrew Jawa, MD
Jay Keener, MD
Scott Steinmann, MD, Chair
Hafiz Kassam, MD, Co-chair
Mark Schultzel, MD
Sean Bak, MD
Edward Bieber, MD
Nate Boes, MD
Curtis Bush, MD
Akin Cil, MD
Kevin Farmer, MD
Gregory Gilot, MD
Kevin Magone, MD
John Timothy Moor, MD
Shadley Schiffern, MD
Misty Suri, MD
David Weinstein, MD
Thomas “Quin” Throckmorton, MD, Ex-officio
Brad Bushnell, MD, Board Liaison
John Sperling, MD, Chair
Hafiz Kassam, MD, Co-chair
Michael Cusick, MD
Ranjan Gupta, MD
Nady Hamid, MD
Samer Hasan, MD
Jason Koh, MD
Surena Namdari, MD
Paul Sethi, MD
Anup Shah, MD
Jennifer Tangtiphaiboontana, MD
Thomas Throckmorton, MD
Corinne VanBeek, MD
Nikhil Verma, MD
April Armstrong, MD, Board Liaison
Jonathan Barlow, MD, 2025 Annual Meeting Co-chair
Robert Hartzler, MD, 2025 Annual Meeting Co-chair
Rachel Frank, MD, 2025 Specialty Day Co-chair
Michael O’Brien, MD, 2025 Specialty Day Co-chair
Carolyn Hettrich, MD, Ex-officio
Michael Khazzam, MD, Ex-officio
Edwin Spencer, MD, Ex-officio
John (Jed) Kuhn, MD, Ex-officio
Joaquin Sanchez-Sotelo, MD, PhD, Ex-officio
Peter Simon, PhD, Chair
Scott Rodeo, MD, Co-chair
William Reuben Aibinder, MD
Brian Badman, MD
Jake Checketts, DO
William Ciccone II, MD
Dennis DeBernardis, MD
Niloofar Dehghan, MD, MSc, FRCSC, FAAOS
Mark Dillon, MD
Catherine Fedorka, MD
Steven Goldberg, MD
Ranjan Gupta, MD
Michael Hachadorian, MD
Tammam Hanna, MD
Samuel Harmsen, MD
John Gabriel Horneff, MD
Joey LaMartina, MD
Nathan Lanham, MD
James Levins, MD
Mario Henrique Lobao, MD
Micah Nieboer, MD
Nata Parnes, MD
Allison Rao, MD
Ryan Rauck, MD
Vani Sabesan, MD
Felix “Buddy” Savoie, MD
Ujash Sheth, MD
Trevor Simcox, MD
Michael Walsh, MD
Ian Whitney, MD
Ivan Wong, MD
Jarret Murray Woodmass, MD
John (Jed) Kuhn, MD, Ex-officio
Robert Tashjian, MD, Board Liaison
Michael J. O’Brien, MD, Co-Chair
Eric T. Ricchetti, MD – Co-Chair
Charles L. Getz, MD, Ex-Officio
Paul M. Sethi, MD, Ex-Officio
Alexander W. Aleem, MD, Chair
Howard Routman, DO, Co-chair
Yousif Atwan, MD
Matthew Budge, MD
Gregory Carolan, MD
Christopher Hart, MD
Jason Ho, MD, MS, FAAOS
Samera Kasim, MD
R. Stephen Otte, MD
Midhat Patel, MD
Djuro Petkovic, MD
Cyrus Press, MD
Brandon Rogalski, MD
Christopher Sheu, MD
Justin Smith, MD
James Stenson, DO
Peter Vezeridis, MD
Eric Wagner, MD
Ed Yian, MD
Joaquin Sanchez-Sotelo, MD, Board Liaison
Vani J. Sabesan, MD (2020)